Trident lifeline promoter Rupaben Chetanbhai Jariwala has increased her shareholding in the company through an open market purchase. The transaction, completed on 02.02.2026, involved the acquisition of 15,600 additional shares, as disclosed under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Transaction Details

The share acquisition represents a modest increase in the promoter's stake in the BSE-listed company. The purchased shares constitute 0.13% of the total share capital and 0.12% of the diluted share capital.

Shareholding Pattern Changes

Prior to this acquisition, Rupaben Chetanbhai Jariwala held 7,18,300 shares in Trident Lifeline Limited, representing 6.02% of the total share capital and 5.74% of the diluted share capital. Following the purchase, her total shareholding has been adjusted to 7,02,700 shares.

Company Capital Structure

Trident Lifeline Limited maintains its equity share capital at Rs. 11,93,30,000, comprising 1,19,33,000 equity shares of Rs. 10 each. The total diluted share capital stands at Rs. 12,49,34,000, representing 1,24,93,400 equity shares of Rs. 10 each, accounting for potential conversion of outstanding convertible securities.

Regulatory Compliance

The disclosure was submitted to BSE Limited in accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Rupaben Chetanbhai Jariwala, based in Surat, Gujarat, continues to hold her position as a promoter of the company. The transaction maintains transparency in shareholding patterns as required by regulatory frameworks governing listed companies in India.

Trident Lifeline Limited has announced that its subsidiary Trident Mediquip Limited has completed a bonus share allotment to existing shareholders. The disclosure was made on February 2, 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Bonus Share Allotment Details

Trident Mediquip Limited (CIN: U33309GJ2019PLC110421) allotted 9,34,160 new bonus shares to Trident Lifeline Limited. Despite receiving these additional shares, Trident Lifeline's percentage shareholding in its subsidiary remains unchanged at 60.04%.

Subsidiary Company Profile

Trident Mediquip Limited was incorporated on October 19, 2019, under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry with a current turnover of 21.29 crore.

Capital Structure

Financial Performance

The subsidiary's turnover performance over the last three financial years shows:

Related Party Transaction

The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Key promoters and directors including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai have interests in both entities. The company has confirmed that the transaction is being undertaken on an arm's length basis.

Regulatory Compliance

The disclosure was made in accordance with SEBI (LODR) Regulations, 2015, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The announcement was signed by Nikita Sharma, Company Secretary and Compliance Officer (M. No.: A60595).